You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
Harvard Business School

Last Updated: December 3, 2023

Drug Sales Trends for NOVOLIN N


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for NOVOLIN N (2020)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $148,084,696
INSIDE ANOTHER STORE $46,624,396
[disabled in preview] $142,669,742
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 330,290
INSIDE ANOTHER STORE 125,945
[disabled in preview] 603,775
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $64,602,531
MEDICARE $242,342,627
[disabled in preview] $30,433,676
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for NOVOLIN N
Drug Units Sold Trends for NOVOLIN N

Annual Sales Revenues and Units Sold for NOVOLIN N

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
NOVOLIN N ⤷  Try a Trial ⤷  Try a Trial 2019
NOVOLIN N ⤷  Try a Trial ⤷  Try a Trial 2018
NOVOLIN N ⤷  Try a Trial ⤷  Try a Trial 2017
NOVOLIN N ⤷  Try a Trial ⤷  Try a Trial 2016
NOVOLIN N ⤷  Try a Trial ⤷  Try a Trial 2015
NOVOLIN N ⤷  Try a Trial ⤷  Try a Trial 2014
NOVOLIN N ⤷  Try a Trial ⤷  Try a Trial 2013
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Merck
Mallinckrodt
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.